imatinib
Imatinib is a small-molecule inhibitor of multiple tyrosine kinases, including ABL, c-KIT, and PDGFR-β. It is primarily used as an active pharmaceutical ingredient in targeted cancer therapy.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 152459-95-5
Imatinib mesylate
active pharmaceutical ingredient
N-Desmethyl N-Nitroso Imatinib
nitrosamine impurity reference standard
N-Desmethyl Imatinib
pharmaceutical metabolite standard
4-[(4-methyl-4-oxidopiperazin-4-ium-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
active pharmaceutical ingredient
Oxytetracycline hemicalcium salt
active pharmaceutical ingredient
Rac Nebivolol hydrochloride
active pharmaceutical ingredient
Trans-Tramadol
active pharmaceutical ingredient
1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone
active pharmaceutical ingredient
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
KTUFNOKKBVMGRW-UHFFFAOYSA-N
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5